OTCMKTS:MKKGY

MERCK Kommanditgesellschaft auf Aktien Stock Forecast, Price & News

$35.31
+0.49 (+1.41 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.94
Now: $35.31▼
$35.33
50-Day Range
$30.68
MA: $33.11▼
$34.81
52-Week Range
$20.06
Now: $35.31▼
$36.50
Volume222,272 shs
Average Volume70,444 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer or multiple sclerosis, infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as carcinoma of the head and neck; prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for the research and applied laboratory applications, as well as for formulating, purifying, manufacturing, and quality-assuring drug therapies of chemical and biological origin; and specialty chemicals, such as liquid crystals and OLED materials for use in displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Intrexon Corporation and Avillion LLP; collaboration with F-star Delta Ltd.; an agreement IAVI and Serum Institute of India Pvt. Ltd. to develop SARS-CoV-2 neutralizing monoclonal antibodies; and collaboration with Iktos for new drug design. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
MERCK Kommanditgesellschaft auf Aktien logo

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MKKGY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.merckgroup.com
Phone+49-6151-720
Employees58,127
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Sees Significant Drop in Short Interest
March 27, 2021 |  americanbankingnews.com
MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Given Average Recommendation of "Hold" by Analysts
March 22, 2021 |  americanbankingnews.com
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer
March 16, 2021 |  finance.yahoo.com
Merck KGaA to boost lipid supply to vaccine maker BioNTech
February 5, 2021 |  finance.yahoo.com
Merck CEO says Covid vaccine won't be a 'silver bullet,' predicts mask use for the 'foreseeable future'
October 29, 2020 |  cnbc.com
Merck KgaA: On The Sidelines Despite The Encouraging Growth Outlook
October 29, 2020 |  seekingalpha.com
Merck’s Digital-Health Venture Arm Quickens Investment Pace
October 29, 2020 |  wsj.com
Merck's Third-Quarter Earnings and Sales Top Forecasts
October 27, 2020 |  msn.com
Merck is about to announce earnings — here's what Wall Street expects
October 27, 2020 |  markets.businessinsider.com
IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
October 23, 2020 |  businesswire.com
Bioburden Testing Market Growing at a Healthy CAGR of 12.4% – Key Players are Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland)
October 19, 2020 |  benzinga.com
Why Precigen Stock Is Skyrocketing Today
October 16, 2020 |  finance.yahoo.com
Merck's Keytruda Gets FDA Nod for Expanded Use in Lymphoma
October 16, 2020 |  nasdaq.com
Salesforce.com Inc., Merck share losses contribute to Dow's 84-point fall
October 15, 2020 |  msn.com
Merck's KEYTRUDA Approved By Health Canada As First-line Treatment In Metastatic Recurrent HNSCC
October 15, 2020 |  markets.businessinsider.com
FDA OKs expanded use of Merck’s Keytruda in adults with classical hodgkin lymphoma
October 15, 2020 |  seekingalpha.com
Part 2: Makaganda seeks Raffy Tulfo's help against Merck Grey, Caffey's mom cries airing her side
October 13, 2020 |  msn.com
Merck KGaA raises stake in Precigen through convertible notes, Shares up 9%
October 9, 2020 |  seekingalpha.com
Novartis nabs osteoarthritis candidate from Germany's Merck
October 6, 2020 |  seekingalpha.com
Merck, Pfizer prevail in patent fight with Biogen over multiple sclerosis drug
September 30, 2020 |  reuters.com
See More Headlines

MarketRank™

Overall MarketRank™

0.46 out of 5 stars

Medical Sector

1669th out of 2,010 stocks

Drug Manufacturers - Specialty & Generic Industry

54th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$35.31
+0.49 (+1.41 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MKKGY News and Ratings via Email

Sign-up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Frequently Asked Questions

Is MERCK Kommanditgesellschaft auf Aktien a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MERCK Kommanditgesellschaft auf Aktien in the last year. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MERCK Kommanditgesellschaft auf Aktien stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MKKGY, but not buy additional shares or sell existing shares.
View analyst ratings for MERCK Kommanditgesellschaft auf Aktien or view top-rated stocks.

What stocks does MarketBeat like better than MERCK Kommanditgesellschaft auf Aktien?

Wall Street analysts have given MERCK Kommanditgesellschaft auf Aktien a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MERCK Kommanditgesellschaft auf Aktien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien saw a drop in short interest in March. As of March 15th, there was short interest totaling 6,600 shares, a drop of 83.0% from the February 28th total of 38,800 shares. Based on an average daily volume of 278,100 shares, the short-interest ratio is presently 0.0 days.
View MERCK Kommanditgesellschaft auf Aktien's Short Interest.

How has MERCK Kommanditgesellschaft auf Aktien's stock been impacted by Coronavirus?

MERCK Kommanditgesellschaft auf Aktien's stock was trading at $21.96 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MKKGY stock has increased by 60.8% and is now trading at $35.3050.
View which stocks have been most impacted by COVID-19.

Who are MERCK Kommanditgesellschaft auf Aktien's key executives?

MERCK Kommanditgesellschaft auf Aktien's management team includes the following people:
  • Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 64)
  • Ms. Belen Garijo Lopez M.D., Vice Chairman of the Exec. Board & Deputy CEO (Age 61)
  • Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 53)
  • Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 56)
  • Mr. Peter Guenter, CEO of Healthcare Bus. & Member of Exec. Board (Age 59)
  • Mr. Gerhard Schmitz, Head of Global Accounting (Age 58)
  • Mr. Dirk Toepfer, Chief Information Officer
  • Mr. Constantin Fest, Head of Investor Relations (Age 44)
  • Dr. Friederike Rotsch, Group Gen. Counsel and Head of Group Legal & Compliance (Age 49)
  • Ms. Barbara Weiland, Chief Compliance Officer (Age 47)

Who are some of MERCK Kommanditgesellschaft auf Aktien's key competitors?

Some companies that are related to MERCK Kommanditgesellschaft auf Aktien include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of MKKGY's competitors.

What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien trades on the OTCMKTS under the ticker symbol "MKKGY."

How do I buy shares of MERCK Kommanditgesellschaft auf Aktien?

Shares of MKKGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MERCK Kommanditgesellschaft auf Aktien's stock price today?

One share of MKKGY stock can currently be purchased for approximately $35.31.

How many employees does MERCK Kommanditgesellschaft auf Aktien have?

MERCK Kommanditgesellschaft auf Aktien employs 58,127 workers across the globe.

What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.

Where are MERCK Kommanditgesellschaft auf Aktien's headquarters?

MERCK Kommanditgesellschaft auf Aktien is headquartered at Frankfurter Strasse 250, DARMSTADT, 64293, Germany.

How can I contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien's mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The company can be reached via phone at +49-6151-720.


This page was last updated on 4/10/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.